Blood Screening Market By Technology (Nucleic Acid Amplification Test (NAT), ELISA, Chemiluminescence Immunoassay (CLIA) & Enzyme Immunoassay (EIA), Next Generation Sequencing, and Western Blotting), By Product (Reagent and Instrument), By End-user (Independent Clinical Laboratories, Hospital-based Laboratories, and Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
- Published date: Aug 2024
- Report ID: 127481
- Number of Pages: 288
- Format:
- keyboard_arrow_up
Table of Contents
- 1. Executive Summary
- 1.1. Definition
- 1.2. Market Snapshot
- 1.3. Market Overview
- 1.4. Segment Overview
- 1.5. Regional Overview
- 1.6. Competitive Landscape
- 1.7. Taxonomy
- 2. Global Market Overview
- 2.1. Global Market Insights and Industry Overview
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunities
- 2.2.4. Key Blood Screening Market Trends
- 2.3. Regulatory Framework
- 2.4. Opportunity Map Analysis
- 2.5. Opportunity Orbits
- 2.6. PESTLE Analysis
- 2.7. PORTER’S Five Force Analysis
- 2.8. Drivers & Restraints Impact Analysis
- 2.9. Value Chain Analysis
- 2.9.1. List of Raw Materials Suppliers
- 2.9.2. List of XYZ Manufacturers
- 2.9.3. List of Dealer/Distributors
- 2.10. Regional Market Share and BPS Analysis
- 2.11. Impact of Macro-economic Factors/Geopolitical Factors
- 3. Global Blood Screening Market Analysis and Forecast, By Segment, 2019-2033
- 3.1. Key Findings
- 3.2. Global Blood Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2019-2033
- 3.3. Global Blood Screening Market Attractiveness Analysis, By Technology
- 3.3.1. Nucleic Acid Amplification Test (NAT)
- 3.3.1.1. Insights
- 3.3.1.2. Key Takeaways
- 3.3.2. ELISA
- 3.3.2.1. Insights
- 3.3.2.2. Key Takeaways
- 3.3.3. Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
- 3.3.3.1. Insights
- 3.3.3.2. Key Takeaways
- 3.3.4. Next Generation Sequencing
- 3.3.4.1. Insights
- 3.3.4.2. Key Takeaways
- 3.3.5. Western Blotting
- 3.3.5.1. Insights
- 3.3.5.2. Key Takeaways
- 3.3.1. Nucleic Acid Amplification Test (NAT)
- 3.4. Global Blood Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2019-2033
- 3.5. Global Blood Screening Market Attractiveness Analysis, By Product
- 3.5.1. Reagent
- 3.5.1.1. Insights
- 3.5.1.2. Key Takeaways
- 3.5.2. Instrument
- 3.5.2.1. Insights
- 3.5.2.2. Key Takeaways
- 3.5.1. Reagent
- 3.6. Global Blood Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End User, 2019-2033
- 3.7. Global Blood Screening Market Attractiveness Analysis, By End User
- 3.7.1. Independent Clinical Laboratories
- 3.7.1.1. Insights
- 3.7.1.2. Key Takeaways
- 3.7.2. Hospital-based Laboratories
- 3.7.2.1. Insights
- 3.7.2.2. Key Takeaways
- 3.7.3. Others
- 3.7.3.1. Insights
- 3.7.3.2. Key Takeaways
- 3.7.1. Independent Clinical Laboratories
- 4. Global Blood Screening Market Analysis and Forecast, By Region, 2019-2033
- 4.1. Key Findings
- 4.2. Global Blood Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2019-2033
- 4.2.1. North America
- 4.2.1.1. Regional Insights
- 4.2.2. Europe
- 4.2.2.1. Regional Insights
- 4.2.3. Asia Pacific
- 4.2.3.1. Regional Insights
- 4.2.4. Latin America
- 4.2.4.1. Regional Insights
- 4.2.5. Middle East & Africa
- 4.2.5.1. Regional Insights
- 4.2.1. North America
- 4.3. Global Blood Screening Market Attractiveness Analysis, By Region
- 5. North America Blood Screening Market Analysis and Forecast, 2019-2033
- 5.1. Key Findings
- 5.2. North America Blood Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2019-2033
- 5.3. North America Blood Screening Market Attractiveness Analysis, By Technology
- 5.4. North America Blood Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2019-2033
- 5.5. North America Blood Screening Market Attractiveness Analysis, By Product
- 5.6. North America Blood Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End User, 2019-2033
- 5.7. North America Blood Screening Market Attractiveness Analysis, By End User
- 5.8. North America Blood Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
- 5.9. North America Blood Screening Market Attractiveness Analysis, By Country
- 5.9.1. The US
- 5.9.2. Canada
- 6. Europe Blood Screening Market Analysis and Forecast, 2019-2033
- 6.1. Key Findings
- 6.2. Europe Blood Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2019-2033
- 6.3. Europe Blood Screening Market Attractiveness Analysis, By Technology
- 6.4. Europe Blood Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2019-2033
- 6.5. Europe Blood Screening Market Attractiveness Analysis, By Product
- 6.6. Europe Blood Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End User, 2019-2033
- 6.7. Europe Blood Screening Market Attractiveness Analysis, By End User
- 6.8. Europe Blood Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
- 6.9. Europe Blood Screening Market Attractiveness Analysis, By Country
- 6.9.1. Germany
- 6.9.2. The UK
- 6.9.3. France
- 6.9.4. Spain
- 6.9.5. Italy
- 6.9.6. Russia
- 6.9.7. Netherland
- 6.9.8. Rest of Europe
- 7. Asia Pacific Blood Screening Market Analysis and Forecast, 2019-2033
- 7.1. Key Findings
- 7.2. Asia Pacific Blood Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2019-2033
- 7.3. Asia Pacific Blood Screening Market Attractiveness Analysis, By Technology
- 7.4. Asia Pacific Blood Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2019-2033
- 7.5. Asia Pacific Blood Screening Market Attractiveness Analysis, By Product
- 7.6. Asia Pacific Blood Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End User, 2019-2033
- 7.7. Asia Pacific Blood Screening Market Attractiveness Analysis, By End User
- 7.8. Asia Pacific Blood Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
- 7.9. Asia Pacific Blood Screening Market Attractiveness Analysis, By Country
- 7.9.1. China
- 7.9.2. Japan
- 7.9.3. South Korea
- 7.9.4. India
- 7.9.5. Australia
- 7.9.6. New Zealand
- 7.9.7. Singapore
- 7.9.8. Thailand
- 7.9.9. Vietnam
- 7.9.10. Rest of Asia Pacific
- 8. Latin America Blood Screening Market Analysis and Forecast, 2019-2033
- 8.1. Key Findings
- 8.2. Latin America Blood Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2019-2033
- 8.3. Latin America Blood Screening Market Attractiveness Analysis, By Technology
- 8.4. Latin America Blood Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2019-2033
- 8.5. Latin America Blood Screening Market Attractiveness Analysis, By Product
- 8.6. Latin America Blood Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End User, 2019-2033
- 8.7. Latin America Blood Screening Market Attractiveness Analysis, By End User
- 8.8. Latin America Blood Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
- 8.9. Latin America Blood Screening Market Attractiveness Analysis, By Country
- 8.9.1. Brazil
- 8.9.2. Mexico
- 8.9.3. Rest of Latin America
- 9. Middle East & Africa Blood Screening Market Analysis and Forecast, 2019-2033
- 9.1. Key Findings
- 9.2. Middle East & Africa Blood Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Technology, 2019-2033
- 9.3. Middle East & Africa Blood Screening Market Attractiveness Analysis, By Technology
- 9.4. Middle East & Africa Blood Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product, 2019-2033
- 9.5. Middle East & Africa Blood Screening Market Attractiveness Analysis, By Product
- 9.6. Middle East & Africa Blood Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End User, 2019-2033
- 9.7. Middle East & Africa Blood Screening Market Attractiveness Analysis, By End User
- 9.8. Middle East & Africa Blood Screening Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2019-2033
- 9.9. Middle East & Africa Blood Screening Market Attractiveness Analysis, By Country
- 9.9.1. South Africa
- 9.9.2. Saudi Arabia
- 9.9.3. UAE
- 9.9.4. Rest of Middle East & Africa
- 10. Competitive Landscape & Company Profiles
- 10.1. Market Competition Scenario Analysis, By Company
- 10.1.1. Key Takeaways
- 10.2. Overview of Major Market Players
- 10.3. Competitor Landscape
- 10.4. Strategic Mapping
- 10.5. Company Life Cycle Analysis
- 10.6. Company Market Share Analysis
- 10.7. Company Profiles
- 10.7.1. Abbott
- 10.7.1.1. Company Details
- 10.7.1.2. Business Overview
- 10.7.1.3. Product Portfolio
- 10.7.1.4. Financial Insights
- 10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.1.6. SWOT Analysis
- 10.7.1.7. Geographic Footprint
- 10.7.2. Siemens Healthcare
- 10.7.2.1. Company Details
- 10.7.2.2. Business Overview
- 10.7.2.3. Product Portfolio
- 10.7.2.4. Financial Insights
- 10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.2.6. SWOT Analysis
- 10.7.2.7. Geographic Footprint
- 10.7.3. Danaher Corporation (Beckman Coulter)
- 10.7.3.1. Company Details
- 10.7.3.2. Business Overview
- 10.7.3.3. Product Portfolio
- 10.7.3.4. Financial Insights
- 10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.3.6. SWOT Analysis
- 10.7.3.7. Geographic Footprint
- 10.7.4. Becton Dickinson and Company
- 10.7.4.1. Company Details
- 10.7.4.2. Business Overview
- 10.7.4.3. Product Portfolio
- 10.7.4.4. Financial Insights
- 10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.4.6. SWOT Analysis
- 10.7.4.7. Geographic Footprint
- 10.7.5. Bio-Rad Laboratories, Inc.
- 10.7.5.1. Company Details
- 10.7.5.2. Business Overview
- 10.7.5.3. Product Portfolio
- 10.7.5.4. Financial Insights
- 10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.5.6. SWOT Analysis
- 10.7.5.7. Geographic Footprint
- 10.7.6. Hoffman-La Roche Ltd.
- 10.7.6.1. Company Details
- 10.7.6.2. Business Overview
- 10.7.6.3. Product Portfolio
- 10.7.6.4. Financial Insights
- 10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.6.6. SWOT Analysis
- 10.7.6.7. Geographic Footprint
- 10.7.7. Grifols, S.A.
- 10.7.7.1. Company Details
- 10.7.7.2. Business Overview
- 10.7.7.3. Product Portfolio
- 10.7.7.4. Financial Insights
- 10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.7.6. SWOT Analysis
- 10.7.7.7. Geographic Footprint
- 10.7.8. Thermo Fisher Scientific, Inc.
- 10.7.8.1. Company Details
- 10.7.8.2. Business Overview
- 10.7.8.3. Product Portfolio
- 10.7.8.4. Financial Insights
- 10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.8.6. SWOT Analysis
- 10.7.8.7. Geographic Footprint
- 10.7.9. Ortho-Clinical Diagnostics, Inc.
- 10.7.9.1. Company Details
- 10.7.9.2. Business Overview
- 10.7.9.3. Product Portfolio
- 10.7.9.4. Financial Insights
- 10.7.9.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.9.6. SWOT Analysis
- 10.7.9.7. Geographic Footprint
- 10.7.10. BIOMÉRIEUX
- 10.7.10.1. Company Details
- 10.7.10.2. Business Overview
- 10.7.10.3. Product Portfolio
- 10.7.10.4. Financial Insights
- 10.7.10.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
- 10.7.10.6. SWOT Analysis
- 10.7.10.7. Geographic Footprint
- 10.7.1. Abbott
- 11. Methodology and Data Source
- 11.1. Methodology/Research Approach
- 11.2. Market Size Estimation
- 11.3. Market Breakdown and Data Triangulation
- 11.4. Data Source
- 11.5. Secondary Sources
- 11.6. Primary Sources
- 11.7. Appendix
- 11.8. Disclaimer
List of Tables
- Table 1. Global Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
- Table 2. Global Blood Screening Market Value (US$ Mn), By Product, 2019-2033
- Table 3. Global Blood Screening Market Value (US$ Mn), By End User, 2019-2033
- Table 4. Global Blood Screening Market Value (US$ Mn), By Region, 2019-2033
- Table 5. North America Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
- Table 6. North America Blood Screening Market Value (US$ Mn), By Product, 2019-2033
- Table 7. North America Blood Screening Market Value (US$ Mn), By End User, 2019-2033
- Table 8. North America Blood Screening Market Value (US$ Mn), By Country, 2019-2033
- Table 9. The US Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
- Table 10. The US Blood Screening Market Value (US$ Mn), By Product, 2019-2033
- Table 11. The US Blood Screening Market Value (US$ Mn), By End User, 2019-2033
- Table 12. Canada Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
- Table 13. Canada Blood Screening Market Value (US$ Mn), By Product, 2019-2033
- Table 14. Canada Blood Screening Market Value (US$ Mn), By End User, 2019-2033
- Table 15. Europe Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
- Table 16. Europe Blood Screening Market Value (US$ Mn), By Product, 2019-2033
- Table 17. Europe Blood Screening Market Value (US$ Mn), By End User, 2019-2033
- Table 18. Europe Blood Screening Market Value (US$ Mn), By Country, 2019-2033
- Table 19. Germany Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
- Table 20. Germany Blood Screening Market Value (US$ Mn), By Product, 2019-2033
- Table 21. Germany Blood Screening Market Value (US$ Mn), By End User, 2019-2033
- Table 22. The UK Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
- Table 23. The UK Blood Screening Market Value (US$ Mn), By Product, 2019-2033
- Table 24. The UK Blood Screening Market Value (US$ Mn), By End User, 2019-2033
- Table 25. France Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
- Table 26. France Blood Screening Market Value (US$ Mn), By Product, 2019-2033
- Table 27. France Blood Screening Market Value (US$ Mn), By End User, 2019-2033
- Table 28. Spain Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
- Table 29. Spain Blood Screening Market Value (US$ Mn), By Product, 2019-2033
- Table 30. Spain Blood Screening Market Value (US$ Mn), By End User, 2019-2033
- Table 31. Italy Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
- Table 32. Italy Blood Screening Market Value (US$ Mn), By Product, 2019-2033
- Table 33. Italy Blood Screening Market Value (US$ Mn), By End User, 2019-2033
- Table 34. Russia Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
- Table 35. Russia Blood Screening Market Value (US$ Mn), By Product, 2019-2033
- Table 36. Russia Blood Screening Market Value (US$ Mn), By End User, 2019-2033
- Table 37. Netherland Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
- Table 38. Netherland Blood Screening Market Value (US$ Mn), By Product, 2019-2033
- Table 39. Netherland Blood Screening Market Value (US$ Mn), By End User, 2019-2033
- Table 40. Rest of Europe Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
- Table 41. Rest of Europe Blood Screening Market Value (US$ Mn), By Product, 2019-2033
- Table 42. Rest of Europe Blood Screening Market Value (US$ Mn), By End User, 2019-2033
- Table 43. Asia Pacific Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
- Table 44. Asia Pacific Blood Screening Market Value (US$ Mn), By Product, 2019-2033
- Table 45. Asia Pacific Blood Screening Market Value (US$ Mn), By End User, 2019-2033
- Table 46. Asia Pacific Blood Screening Market Value (US$ Mn), By Country, 2019-2033
- Table 47. China Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
- Table 48. China Blood Screening Market Value (US$ Mn), By Product, 2019-2033
- Table 49. China Blood Screening Market Value (US$ Mn), By End User, 2019-2033
- Table 50. India Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
- Table 51. India Blood Screening Market Value (US$ Mn), By Product, 2019-2033
- Table 52. India Blood Screening Market Value (US$ Mn), By End User, 2019-2033
- Table 53. Japan Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
- Table 54. Japan Blood Screening Market Value (US$ Mn), By Product, 2019-2033
- Table 55. Japan Blood Screening Market Value (US$ Mn), By End User, 2019-2033
- Table 56. South Korea Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
- Table 57. South Korea Blood Screening Market Value (US$ Mn), By Product, 2019-2033
- Table 58. South Korea Blood Screening Market Value (US$ Mn), By End User, 2019-2033
- Table 59. Australia Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
- Table 60. Australia Blood Screening Market Value (US$ Mn), By Product, 2019-2033
- Table 61. Australia Blood Screening Market Value (US$ Mn), By End User, 2019-2033
- Table 62. New Zealand Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
- Table 63. New Zealand Blood Screening Market Value (US$ Mn), By Product, 2019-2033
- Table 64. New Zealand Blood Screening Market Value (US$ Mn), By End User, 2019-2033
- Table 65. Singapore Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
- Table 66. Singapore Blood Screening Market Value (US$ Mn), By Product, 2019-2033
- Table 67. Singapore Blood Screening Market Value (US$ Mn), By End User, 2019-2033
- Table 68. Thailand Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
- Table 69. Thailand Blood Screening Market Value (US$ Mn), By Product, 2019-2033
- Table 70. Thailand Blood Screening Market Value (US$ Mn), By End User, 2019-2033
- Table 71. Vietnam Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
- Table 72. Vietnam Blood Screening Market Value (US$ Mn), By Product, 2019-2033
- Table 73. Vietnam Blood Screening Market Value (US$ Mn), By End User, 2019-2033
- Table 74. Rest of Asia Pacific Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
- Table 75. Rest of Asia Pacific Blood Screening Market Value (US$ Mn), By Product, 2019-2033
- Table 76. Rest of Asia Pacific Blood Screening Market Value (US$ Mn), By End User, 2019-2033
- Table 77. Latin America Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
- Table 78. Latin America Blood Screening Market Value (US$ Mn), By Product, 2019-2033
- Table 79. Latin America Blood Screening Market Value (US$ Mn), By End User, 2019-2033
- Table 80. Latin America Blood Screening Market Value (US$ Mn), By Country, 2019-2033
- Table 81. Brazil Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
- Table 82. Brazil Blood Screening Market Value (US$ Mn), By Product, 2019-2033
- Table 83. Brazil Blood Screening Market Value (US$ Mn), By End User, 2019-2033
- Table 84. Mexico Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
- Table 85. Mexico Blood Screening Market Value (US$ Mn), By Product, 2019-2033
- Table 86. Mexico Blood Screening Market Value (US$ Mn), By End User, 2019-2033
- Table 87. Rest of Latin America Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
- Table 88. Rest of Latin America Blood Screening Market Value (US$ Mn), By Product, 2019-2033
- Table 89. Rest of Latin America Blood Screening Market Value (US$ Mn), By End User, 2019-2033
- Table 90. Middle East & Africa Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
- Table 91. Middle East & Africa Blood Screening Market Value (US$ Mn), By Product, 2019-2033
- Table 92. Middle East & Africa Blood Screening Market Value (US$ Mn), By End User, 2019-2033
- Table 93. Middle East & Africa Blood Screening Market Value (US$ Mn), By Country, 2019-2033
- Table 94. South Africa Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
- Table 95. South Africa Blood Screening Market Value (US$ Mn), By Product, 2019-2033
- Table 96. South Africa Blood Screening Market Value (US$ Mn), By End User, 2019-2033
- Table 97. Saudi Arabia Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
- Table 98. Saudi Arabia Blood Screening Market Value (US$ Mn), By Product, 2019-2033
- Table 99. Saudi Arabia Blood Screening Market Value (US$ Mn), By End User, 2019-2033
- Table 100. UAE Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
- Table 101. UAE Blood Screening Market Value (US$ Mn), By Product, 2019-2033
- Table 102. UAE Blood Screening Market Value (US$ Mn), By End User, 2019-2033
- Table 103. Rest of Middle East & Africa Blood Screening Market Value (US$ Mn), By Technology, 2019-2033
- Table 104. Rest of Middle East & Africa Blood Screening Market Value (US$ Mn), By Product, 2019-2033
- Table 105. Rest of Middle East & Africa Blood Screening Market Value (US$ Mn), By End User, 2019-2033
List of Figures
- Figure 1. Global Blood Screening Market Snapshot: Market Value (US$ Mn), 2019-2033
- Figure 2. Opportunity Map
- Figure 3. Opportunity Orbit
- Figure 4. Regional Market Share and BPS Analysis in Blood Screening Market
- Figure 5. Global Blood Screening Market Analysis, By Technology, 2019, 2023 and 2033
- Figure 6. Global Blood Screening Market Attractiveness Analysis, By Technology
- Figure 7. Global Blood Screening Market Analysis, By Product, 2019, 2023 and 2033
- Figure 8. Global Blood Screening Market Attractiveness Analysis, By Product
- Figure 9. Global Blood Screening Market Analysis, By End User, 2019, 2023 and 2033
- Figure 10. Global Blood Screening Market Attractiveness Analysis, By End User
- Figure 11. Global Blood Screening Market Analysis, By Region, 2019, 2023 and 2033
- Figure 12. Global Blood Screening Market Attractiveness Analysis, By Region
- Figure 13. North America Blood Screening Market Analysis, By Technology, 2019, 2023 and 2033
- Figure 14. North America Blood Screening Market Attractiveness Analysis, By Technology
- Figure 15. North America Blood Screening Market (US$ Mn), By Nucleic Acid Amplification Test (NAT), 2019-2033
- Figure 16. North America Blood Screening Market (US$ Mn), By ELISA, 2019-2033
- Figure 17. North America Blood Screening Market (US$ Mn), By Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA), 2019-2033
- Figure 18. North America Blood Screening Market (US$ Mn), By Next Generation Sequencing, 2019-2033
- Figure 19. North America Blood Screening Market (US$ Mn), By Western Blotting, 2019-2033
- Figure 20. North America Blood Screening Market Analysis, By Product, 2019, 2023 and 2033
- Figure 21. North America Blood Screening Market Attractiveness Analysis, By Product
- Figure 22. North America Blood Screening Market (US$ Mn), by Reagent, 2019-2033
- Figure 23. North America Blood Screening Market (US$ Mn), by Instrument, 2019-2033
- Figure 24. North America Blood Screening Market Analysis, By End User, 2019, 2023 and 2033
- Figure 25. North America Blood Screening Market Attractiveness Analysis, By End User
- Figure 26. North America Blood Screening Market (US$ Mn), By Independent Clinical Laboratories, 2019-2033
- Figure 27. North America Blood Screening Market (US$ Mn), By Hospital-based Laboratories, 2019-2033
- Figure 28. North America Blood Screening Market (US$ Mn), By Others, 2019-2033
- Figure 29. North America Blood Screening Market Analysis, By Country, 2019, 2023 and 2033
- Figure 30. North America Blood Screening Market Attractiveness Analysis, By Country
- Figure 31. Europe Blood Screening Market Analysis, By Technology, 2019, 2023 and 2033
- Figure 32. Europe Blood Screening Market Attractiveness Analysis, By Technology
- Figure 33. Europe Blood Screening Market (US$ Mn), By Nucleic Acid Amplification Test (NAT), 2019-2033
- Figure 34. Europe Blood Screening Market (US$ Mn), By ELISA, 2019-2033
- Figure 35. Europe Blood Screening Market (US$ Mn), By Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA), 2019-2033
- Figure 36. Europe Blood Screening Market (US$ Mn), By Next Generation Sequencing, 2019-2033
- Figure 37. Europe Blood Screening Market (US$ Mn), By Western Blotting, 2019-2033
- Figure 38. Europe merica Blood Screening Market Analysis, By Product, 2019, 2023 and 2033
- Figure 39. Europe Blood Screening Market Attractiveness Analysis, By Product
- Figure 40. Europe Blood Screening Market (US$ Mn), by Reagent, 2019-2033
- Figure 41. Europe Blood Screening Market (US$ Mn), by Instrument, 2019-2033
- Figure 42. Europe Blood Screening Market Analysis, By End User, 2019, 2023 and 2033
- Figure 43. Europe Blood Screening Market Attractiveness Analysis, By End User
- Figure 44. Europe Blood Screening Market (US$ Mn), By Independent Clinical Laboratories, 2019-2033
- Figure 45. Europe Blood Screening Market (US$ Mn), By Hospital-based Laboratories, 2019-2033
- Figure 46. Europe Blood Screening Market (US$ Mn), By Others, 2019-2033
- Figure 47. Europe Blood Screening Market Analysis, By Country, 2019, 2023 and 2033
- Figure 48. Europe Blood Screening Market Attractiveness Analysis, By Country
- Figure 49. Asia Pacific Blood Screening Market Analysis, By Technology, 2019, 2023 and 2033
- Figure 50. Asia Pacific Blood Screening Market Attractiveness Analysis, By Technology
- Figure 51. Asia Pacific Blood Screening Market (US$ Mn), By Nucleic Acid Amplification Test (NAT), 2019-2033
- Figure 52. Asia Pacific Blood Screening Market (US$ Mn), By ELISA, 2019-2033
- Figure 53. Asia Pacific Blood Screening Market (US$ Mn), By Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA), 2019-2033
- Figure 54. Asia Pacific Blood Screening Market (US$ Mn), By Next Generation Sequencing, 2019-2033
- Figure 55. Asia Pacific Blood Screening Market (US$ Mn), By Western Blotting, 2019-2033
- Figure 56. Asia Pacific merica Blood Screening Market Analysis, By Product, 2019, 2023 and 2033
- Figure 57. Asia Pacific Blood Screening Market Attractiveness Analysis, By Product
- Figure 58. Asia Pacific Blood Screening Market (US$ Mn), by Reagent, 2019-2033
- Figure 59. Asia Pacific Blood Screening Market (US$ Mn), by Instrument, 2019-2033
- Figure 60. Asia Pacific Blood Screening Market Analysis, By End User, 2019, 2023 and 2033
- Figure 61. Asia Pacific Blood Screening Market Attractiveness Analysis, By End User
- Figure 62. Asia Pacific Blood Screening Market (US$ Mn), By Independent Clinical Laboratories, 2019-2033
- Figure 63. Asia Pacific Blood Screening Market (US$ Mn), By Hospital-based Laboratories, 2019-2033
- Figure 64. Asia Pacific Blood Screening Market (US$ Mn), By Others, 2019-2033
- Figure 65. Asia Pacific Blood Screening Market Analysis, By Country, 2019, 2023 and 2033
- Figure 66. Asia Pacific Blood Screening Market Attractiveness Analysis, By Country
- Figure 67. Latin America Blood Screening Market Analysis, By Technology, 2019, 2023 and 2033
- Figure 68. Latin America Blood Screening Market Attractiveness Analysis, By Technology
- Figure 69. Latin America Blood Screening Market (US$ Mn), By Nucleic Acid Amplification Test (NAT), 2019-2033
- Figure 70. Latin America Blood Screening Market (US$ Mn), By ELISA, 2019-2033
- Figure 71. Latin America Blood Screening Market (US$ Mn), By Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA), 2019-2033
- Figure 72. Latin America Blood Screening Market (US$ Mn), By Next Generation Sequencing, 2019-2033
- Figure 73. Latin America Blood Screening Market (US$ Mn), By Western Blotting, 2019-2033
- Figure 74. Latin America merica Blood Screening Market Analysis, By Product, 2019, 2023 and 2033
- Figure 75. Latin America Blood Screening Market Attractiveness Analysis, By Product
- Figure 76. Latin America Blood Screening Market (US$ Mn), by Reagent, 2019-2033
- Figure 77. Latin America Blood Screening Market (US$ Mn), by Instrument, 2019-2033
- Figure 78. Latin America Blood Screening Market Analysis, By End User, 2019, 2023 and 2033
- Figure 79. Latin America Blood Screening Market Attractiveness Analysis, By End User
- Figure 80. Latin America Blood Screening Market (US$ Mn), By Independent Clinical Laboratories, 2019-2033
- Figure 81. Latin America Blood Screening Market (US$ Mn), By Hospital-based Laboratories, 2019-2033
- Figure 82. Latin America Blood Screening Market (US$ Mn), By Others, 2019-2033
- Figure 83. Latin America Blood Screening Market Analysis, By Country, 2019, 2023 and 2033
- Figure 84. Latin America Blood Screening Market Attractiveness Analysis, By Country
- Figure 85. Middle East & Africa Blood Screening Market Analysis, By Technology, 2019, 2023 and 2033
- Figure 86. Middle East & Africa Blood Screening Market Attractiveness Analysis, By Technology
- Figure 87. Middle East & Africa Blood Screening Market (US$ Mn), By Nucleic Acid Amplification Test (NAT), 2019-2033
- Figure 88. Middle East & Africa Blood Screening Market (US$ Mn), By ELISA, 2019-2033
- Figure 89. Middle East & Africa Blood Screening Market (US$ Mn), By Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA), 2019-2033
- Figure 90. Middle East & Africa Blood Screening Market (US$ Mn), By Next Generation Sequencing, 2019-2033
- Figure 91. Middle East & Africa Blood Screening Market (US$ Mn), By Western Blotting, 2019-2033
- Figure 92. Middle East & Africa merica Blood Screening Market Analysis, By Product, 2019, 2023 and 2033
- Figure 93. Middle East & Africa Blood Screening Market Attractiveness Analysis, By Product
- Figure 94. Middle East & Africa Blood Screening Market (US$ Mn), by Reagent, 2019-2033
- Figure 95. Middle East & Africa Blood Screening Market (US$ Mn), by Instrument, 2019-2033
- Figure 96. Middle East & Africa Blood Screening Market Analysis, By End User, 2019, 2023 and 2033
- Figure 97. Middle East & Africa Blood Screening Market Attractiveness Analysis, By End User
- Figure 98. Middle East & Africa Blood Screening Market (US$ Mn), By Independent Clinical Laboratories, 2019-2033
- Figure 99. Middle East & Africa Blood Screening Market (US$ Mn), By Hospital-based Laboratories, 2019-2033
- Figure 100. Middle East & Africa Blood Screening Market (US$ Mn), By Others, 2019-2033
- Figure 101. Middle East & Africa Blood Screening Market Analysis, By Country, 2019, 2023 and 2033
- Figure 102. Middle East & Africa Blood Screening Market Attractiveness Analysis, By Country
- 1. Executive Summary
- Abbott Laboratories
- Siemens Healthcare
- Danaher Corporation (Beckman Coulter)
- Becton Dickinson and Company
- Bio-Rad Laboratories, Inc. Company Profile
- Hoffman-La Roche Ltd.
- Grifols, S.A.
- Thermo Fisher Scientific, Inc.
- Ortho-Clinical Diagnostics, Inc.
- BIOMÉRIEUX
- settingsSettings
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible Single User $6,000 $3,999 USD / per unit save 24% | Multi User $8,000 $5,999 USD / per unit save 28% | Corporate User $10,000 $6,999 USD / per unit save 32% | |
---|---|---|---|
e-Access | |||
Report Library Access | |||
Data Set (Excel) | |||
Company Profile Library Access | |||
Interactive Dashboard | |||
Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
Accessibility | 1 User | 2-5 User | Unlimited |
Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
Buy Now ($ 3,999) | Buy Now ($ 5,999) | Buy Now ($ 6,999) |